HEADER TRANSFERASE 13-OCT-07 2RIY TITLE B-SPECIFIC-1,3-GALACTOSYLTRANSFERASE (GTB)+H-ANTIGEN ACCEPTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOPROTEIN-FUCOSYLGALACTOSIDE ALPHA- COMPND 3 GALACTOSYLTRANSFERASE; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: FUCOSYLGLYCOPROTEIN 3-ALPHA- GALACTOSYLTRANSFERASE, HISTO- COMPND 6 BLOOD GROUP B TRANSFERASE, B TRANSFERASE; COMPND 7 EC: 2.4.1.37; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABO; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21GOLD; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCW DELTA 1AC KEYWDS GTB ABO ROSSMAN FOLD BBBB UNLIGANDED, BLOOD GROUP ANTIGEN, KEYWDS 2 GLYCOPROTEIN, GLYCOSYLTRANSFERASE, GOLGI APPARATUS, MANGANESE, KEYWDS 3 MEMBRANE, METAL-BINDING, SECRETED, SIGNAL-ANCHOR, TRANSFERASE, KEYWDS 4 TRANSMEMBRANE EXPDTA X-RAY DIFFRACTION AUTHOR S.V.EVANS,J.A.ALFARO REVDAT 6 21-FEB-24 2RIY 1 REMARK REVDAT 5 07-MAR-18 2RIY 1 REMARK REVDAT 4 13-JUL-11 2RIY 1 VERSN REVDAT 3 24-FEB-09 2RIY 1 VERSN REVDAT 2 27-MAY-08 2RIY 1 JRNL REVDAT 1 05-FEB-08 2RIY 0 JRNL AUTH J.A.ALFARO,R.B.ZHENG,M.PERSSON,J.A.LETTS,R.POLAKOWSKI,Y.BAI, JRNL AUTH 2 S.N.BORISOVA,N.O.SETO,T.L.LOWARY,M.M.PALCIC,S.V.EVANS JRNL TITL ABO(H) BLOOD GROUP A AND B GLYCOSYLTRANSFERASES RECOGNIZE JRNL TITL 2 SUBSTRATE VIA SPECIFIC CONFORMATIONAL CHANGES. JRNL REF J.BIOL.CHEM. V. 283 10097 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18192272 JRNL DOI 10.1074/JBC.M708669200 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 45166 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2284 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.59 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3046 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.74 REMARK 3 BIN R VALUE (WORKING SET) : 0.4400 REMARK 3 BIN FREE R VALUE SET COUNT : 166 REMARK 3 BIN FREE R VALUE : 0.5650 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2254 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 240 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.02000 REMARK 3 B22 (A**2) : 0.01000 REMARK 3 B33 (A**2) : 0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.093 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.090 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.057 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.540 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.950 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2346 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3185 ; 1.282 ; 1.962 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 273 ; 6.003 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 111 ;32.553 ;22.613 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 388 ;12.968 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;20.043 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 353 ; 0.088 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1769 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1173 ; 0.206 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1628 ; 0.312 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 205 ; 0.150 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 61 ; 0.204 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 19 ; 0.141 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1410 ; 0.871 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2239 ; 1.313 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1069 ; 2.016 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 946 ; 3.026 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2RIY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1000044914. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 113 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK 9.4SSI REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45171 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 19.870 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 4.910 REMARK 200 R MERGE (I) : 0.03700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.07 REMARK 200 R MERGE FOR SHELL (I) : 0.31800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000 GLYCEROL MGCL NH2SO4, PH 7.5, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.69000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.69000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 26.28000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 75.12500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 26.28000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 75.12500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 39.69000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 26.28000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 75.12500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 39.69000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 26.28000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 75.12500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -52.56000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 39.69000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 543 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 627 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 176 REMARK 465 ALA A 177 REMARK 465 TYR A 178 REMARK 465 LYS A 179 REMARK 465 ARG A 180 REMARK 465 TRP A 181 REMARK 465 GLN A 182 REMARK 465 ASP A 183 REMARK 465 VAL A 184 REMARK 465 LYS A 346 REMARK 465 ASN A 347 REMARK 465 HIS A 348 REMARK 465 GLN A 349 REMARK 465 ALA A 350 REMARK 465 VAL A 351 REMARK 465 ARG A 352 REMARK 465 ASN A 353 REMARK 465 PRO A 354 REMARK 465 GLU A 355 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 124 -127.35 52.54 REMARK 500 THR A 245 47.05 -85.29 REMARK 500 PHE A 269 99.86 -161.79 REMARK 500 HIS A 301 -132.26 56.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 BHE A 452 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BHE A 452 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2RIT RELATED DB: PDB REMARK 900 RELATED ID: 2RIX RELATED DB: PDB REMARK 900 RELATED ID: 2RIZ RELATED DB: PDB REMARK 900 RELATED ID: 2RJ0 RELATED DB: PDB REMARK 900 RELATED ID: 2RJ1 RELATED DB: PDB REMARK 900 RELATED ID: 2RJ4 RELATED DB: PDB REMARK 900 RELATED ID: 2RJ5 RELATED DB: PDB REMARK 900 RELATED ID: 2RJ6 RELATED DB: PDB REMARK 900 RELATED ID: 2RJ7 RELATED DB: PDB REMARK 900 RELATED ID: 2RJ8 RELATED DB: PDB REMARK 900 RELATED ID: 2RJ9 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE OF THIS PROTEIN CORRESPONDS TO WILD TYPE HISTO-BLOOD REMARK 999 GROUP B TRANSFERASE. THE SEQUENCE DIFFERENCES WITH UNP ENTRY P16442 REMARK 999 CORRESPOND TO THE VARIENTS BETWEEN P16442 AND GROUP B TRANSFERASE, REMARK 999 AS INDICATED IN THE DESCRIPTION OF P16442. DBREF 2RIY A 64 354 UNP P16442 BGAT_HUMAN 64 354 SEQADV 2RIY PHE A 62 UNP P16442 EXPRESSION TAG SEQADV 2RIY MET A 63 UNP P16442 EXPRESSION TAG SEQADV 2RIY GLY A 176 UNP P16442 ARG 176 SEE REMARK 999 SEQADV 2RIY SER A 235 UNP P16442 GLY 235 SEE REMARK 999 SEQADV 2RIY MET A 266 UNP P16442 LEU 266 SEE REMARK 999 SEQADV 2RIY ALA A 268 UNP P16442 GLY 268 SEE REMARK 999 SEQADV 2RIY GLU A 355 UNP P16442 EXPRESSION TAG SEQRES 1 A 294 PHE MET VAL SER LEU PRO ARG MET VAL TYR PRO GLN PRO SEQRES 2 A 294 LYS VAL LEU THR PRO CYS ARG LYS ASP VAL LEU VAL VAL SEQRES 3 A 294 THR PRO TRP LEU ALA PRO ILE VAL TRP GLU GLY THR PHE SEQRES 4 A 294 ASN ILE ASP ILE LEU ASN GLU GLN PHE ARG LEU GLN ASN SEQRES 5 A 294 THR THR ILE GLY LEU THR VAL PHE ALA ILE LYS LYS TYR SEQRES 6 A 294 VAL ALA PHE LEU LYS LEU PHE LEU GLU THR ALA GLU LYS SEQRES 7 A 294 HIS PHE MET VAL GLY HIS ARG VAL HIS TYR TYR VAL PHE SEQRES 8 A 294 THR ASP GLN PRO ALA ALA VAL PRO ARG VAL THR LEU GLY SEQRES 9 A 294 THR GLY ARG GLN LEU SER VAL LEU GLU VAL GLY ALA TYR SEQRES 10 A 294 LYS ARG TRP GLN ASP VAL SER MET ARG ARG MET GLU MET SEQRES 11 A 294 ILE SER ASP PHE CYS GLU ARG ARG PHE LEU SER GLU VAL SEQRES 12 A 294 ASP TYR LEU VAL CYS VAL ASP VAL ASP MET GLU PHE ARG SEQRES 13 A 294 ASP HIS VAL GLY VAL GLU ILE LEU THR PRO LEU PHE GLY SEQRES 14 A 294 THR LEU HIS PRO SER PHE TYR GLY SER SER ARG GLU ALA SEQRES 15 A 294 PHE THR TYR GLU ARG ARG PRO GLN SER GLN ALA TYR ILE SEQRES 16 A 294 PRO LYS ASP GLU GLY ASP PHE TYR TYR MET GLY ALA PHE SEQRES 17 A 294 PHE GLY GLY SER VAL GLN GLU VAL GLN ARG LEU THR ARG SEQRES 18 A 294 ALA CYS HIS GLN ALA MET MET VAL ASP GLN ALA ASN GLY SEQRES 19 A 294 ILE GLU ALA VAL TRP HIS ASP GLU SER HIS LEU ASN LYS SEQRES 20 A 294 TYR LEU LEU ARG HIS LYS PRO THR LYS VAL LEU SER PRO SEQRES 21 A 294 GLU TYR LEU TRP ASP GLN GLN LEU LEU GLY TRP PRO ALA SEQRES 22 A 294 VAL LEU ARG LYS LEU ARG PHE THR ALA VAL PRO LYS ASN SEQRES 23 A 294 HIS GLN ALA VAL ARG ASN PRO GLU HET BHE A 452 28 HETNAM BHE OCTYL 2-O-(6-DEOXY-ALPHA-L-GALACTOPYRANOSYL)-BETA-D- HETNAM 2 BHE GALACTOPYRANOSIDE HETSYN BHE H-ANTIGEN ACCEPTOR; ALPHA-L-FUCP-(1,2)-BETA-D-GALP- HETSYN 2 BHE O(CH2)7CH3 FORMUL 2 BHE C20 H38 O10 FORMUL 3 HOH *240(H2 O) HELIX 1 1 ASN A 101 GLN A 112 1 12 HELIX 2 2 ILE A 123 ALA A 128 5 6 HELIX 3 3 PHE A 129 PHE A 141 1 13 HELIX 4 4 GLN A 155 VAL A 159 5 5 HELIX 5 5 MET A 186 ASP A 194 1 9 HELIX 6 6 CYS A 196 VAL A 204 1 9 HELIX 7 7 GLY A 221 LEU A 225 5 5 HELIX 8 8 SER A 240 PHE A 244 5 5 HELIX 9 9 VAL A 274 ASN A 294 1 21 HELIX 10 10 HIS A 301 HIS A 313 1 13 HELIX 11 11 PRO A 321 LEU A 324 5 4 HELIX 12 12 ASP A 326 GLY A 331 1 6 SHEET 1 A 8 ILE A 94 VAL A 95 0 SHEET 2 A 8 LYS A 317 LEU A 319 1 O VAL A 318 N VAL A 95 SHEET 3 A 8 LEU A 228 THR A 231 1 N GLY A 230 O LEU A 319 SHEET 4 A 8 PHE A 269 SER A 273 -1 O GLY A 271 N PHE A 229 SHEET 5 A 8 TYR A 206 VAL A 210 -1 N CYS A 209 O PHE A 270 SHEET 6 A 8 THR A 115 ALA A 122 1 N GLY A 117 O TYR A 206 SHEET 7 A 8 ARG A 146 THR A 153 1 O PHE A 152 N ALA A 122 SHEET 8 A 8 ARG A 168 GLU A 174 1 O LEU A 173 N VAL A 151 SHEET 1 B 2 MET A 214 PHE A 216 0 SHEET 2 B 2 PHE A 341 ALA A 343 -1 O THR A 342 N GLU A 215 SITE 1 AC1 12 HIS A 233 SER A 235 PHE A 236 THR A 245 SITE 2 AC1 12 MET A 266 TRP A 300 GLU A 303 ASP A 326 SITE 3 AC1 12 HOH A 524 HOH A 594 HOH A 613 HOH A 671 CRYST1 52.560 150.250 79.380 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019026 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006656 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012598 0.00000